Literatur
Anderson TJ, Meredith IT, Yeung AC, et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995;23:488–93.
Andrews T.C., Raby K., Barry J., Naimi C.L., Allred E., Ganz P., Selwyn A.P.: Effect of Cholesterol Reduction on Myocardial Ischemia in Patients with Coronary Disease. Circulation 95 (1997), 324–327
van Boven A. J., Jukema J. W., Zwindermann A. H., Crijns H. J. G. M., Lie K. J., Bruschke A. V. G.: Reduction of Transient Myocardial Ischemia with Pravastatin in Addition to the Conventional Treatment in Patients with Angina Pectoris. Circulation 94 (1996), 1503–1505
Brown B. G., Zhao X-Q, Sacco D. E., Albers J. J.: Lipid Lowering and Plaque Regression. Circulation 87 (1993), 1781–1791
Cannon R. O.: Does Coronary Endothelial Dysfunction Cause Myocardial Ischemia in the Absence of Obstructive coronary Artery Disease? Circulation 96 (1997), 3251–3254
Celermajer D. S.: Endothelial Dysfunction: Does it Matter? Is it Reversible? JACC 30 (1997), 325–333
Clarkson P., Celermajor D. S., Powe A. J., Donald A. E., Henry R. M. A., Deanfieldn, J. E.: Endothelium-Dependent Dilatation Is Impaired in Young Healthy Subjects with a Family History of Premature Coronary Disease. Circulation 96 (1997), 3378–3383
Egashira K., Hirooka Y., Kai H., Sugimachi M., Suzuki S., Takeshita A.: Reduction in Serum Cholesterol With Pravastatin Improves Endothelium-Dependent Coronary Vasomotion in Patients With Hypercholesterolemia. Circulation 89 (1994) 2519–2524
Fuster V., Poon, M., Willerson J. T.: Learning from the Transgenic Mouse. Circulation 97 (1997), 16–18
Hasdai D., Gibbons R. J., Holmes D. R., Higano S. T., Lerman A.: Coronary Endothelial Dysfunction in Humans Is Associated with Myocardial Perfusion Defects. Circulation 96 (1997), 3390–3395
Kinlay S., Selwyn A. P., Delagrange D., Creager M. A., Libby P., Ganz P.: Biological mechanisms for the clinical success of lipid-lowering in coronary artery diesease and the use of surrogate end-points. Curr Opin Lipidol 7 (1996), 389–397.
Lacoste L., Lam J. Y. T., Hung, J., Letchacovski G., Solymoss C. B., Walters D.: Hyperlipidemia and Coronary Disease. Correction of the Increased Thrombogenic Potential with Cholesterol Reduction. Circulation 92 (1995), 3172–3177
Laufs U., La Fata V., Liao J. K.: Inhibition of 3-Hydroxy-3-methylglutariy (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide Synthase. JBC 272 (1997), 31725–31729
Laufs U., La Fata V., Plutzky J., Liao J. K.: Upregulation of Endothelial Nitric Oxide Synthase by HMG-CoA Reductase Inhibitors. Circulation 97 (1998), 1129–1135
Libby P.: Molecular basis of the acute coronary syndrome. Circulation 91 (1995), 2844–2850
Müller-Wieland D., Kotzka J., Krone W.: Stabilization of atherosclerotic plaque during lipid lowering. Curr Opin Lipidol 8 (1997), 348–353
Müller-Wieland D., Faust M., Krone W.: Cholesterinsynthesehemmer — Klinische Studien zur Senkung des koronaren Risikos und Plaque-Stabilisierung. Internist 39 (1998) 934–942
Münzel T., Heitzer T., Harrison D. G.: The Physiology and Pathophysiology of the Nitric Oxide/Superoxide System. Herz 22 (1997), 157–172.
O’Driscoll G., Green D., Taylor R. R.: Simvastatin, an HMG-Coenzyme A Reductase Inhibitor, Improves Endothelial Function within 1 Month. Circulation 95 (1997) 1126–1131
Rosenson R. S., Tangney C. C.: Antiatherothrombotic Properties of Statins. JAMA 27 (1998), 1643–1650
Sampietro T., Tuoni, M., Ferdeghini, M., Ciardi A., Marraccini P., Pronterea C., Sassi G., Taddei M., Bionda A.: Plasma Cholesterol Regulates Soluble Cell Adhesion Molecule Expression in Familial Hypercholesterolemia. Circulation 96 (1997), 1381–1385
Tamai O., Matsuoka H., Itabe H., Wada Y., Kohno K., Imaizumi T.: Single LDL Apheresis Improves Endothelium-Dependent Vasodilatation in Hypercholesterolemic Human. Circulation 95 (1997), 76–82.
Treasure C. B., Klein J. L., Weintraub W. S., Talley J. D., Stillabower M. E., Kosinski A. S., Zhang J., Boccuzzi S. J., Cedarholm J. C., Alexander R. W.: Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery Disease. N Engl J Med 332 (1995), 481–487
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Müller-Wieland, D., Faust, M., Kotzka, J. et al. Plaquestabilisierung und Endothelschutz durch Cholesterin-synthesehemmer. Herz 24, 254–257 (1999). https://doi.org/10.1007/BF03044972
Issue Date:
DOI: https://doi.org/10.1007/BF03044972